Cargando…

Past history of stage I/II solid tumor malignancy impacts considerably on sepsis mortality: a propensity score matching analysis from the hellenic sepsis study group

BACKGROUND: Whether past history of solid stage I/II inactive cancer has an impact on 28-day mortality of sepsis remains unclear. We aimed to determine the impact of history of stage I or II solid tumor malignancy in complete remission the last 3 years on sepsis outcome. METHODS: Using the database...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dimοpoulos, George, Rovina, Nikoletta, Patrani, Maria, Antoniadou, Eleni, Konstantonis, Dimitrios, Vryza, Konstantina, Vlachogianni, Glykeria, Kyprianou, Miltiades, Routsi, Christina, Giamarellos-Bourboulis, Evangelos J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781365/ https://www.ncbi.nlm.nih.gov/pubmed/31590654 http://dx.doi.org/10.1186/s12879-019-4448-7

Ejemplares similares

Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial
por: Leventogiannis, Konstantinos, et al.
Publicado: (2022)

Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis*
por: Karakike, Eleni, et al.
Publicado: (2021)

Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial
por: Karakike, Eleni, et al.
Publicado: (2022)

A novel optical biosensor for the early diagnosis of sepsis and severe Covid-19: the PROUD study
por: Doulou, Sarantia, et al.
Publicado: (2020)

Soluble usokinase plasminogen activator receptor as a useful biomarker to define advent of sepsis in patients with multiple injuries
por: Patrani, M, et al.
Publicado: (2012)

Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2013)

Sepsis: Diagnostic and Therapeutic Challenges
por: Molnár, Zsolt, et al.
Publicado: (2016)

The early change of SOFA score as a prognostic marker of 28-day sepsis mortality: analysis through a derivation and a validation cohort
por: Karakike, Eleni, et al.
Publicado: (2019)

Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group
por: Velissaris, Dimitrios, et al.
Publicado: (2020)

Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis
por: Karakike, Eleni, et al.
Publicado: (2019)

-572 G/C single nucleotide polymorphism of interleukin-6 and sepsis predisposition in chronic renal disease
por: Panayides, A., et al.
Publicado: (2015)

Compartmentalization of lipid peroxidation in sepsis by multidrug-resistant gram-negative bacteria: experimental and clinical evidence
por: Toufekoula, Chryssoula, et al.
Publicado: (2013)

Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
por: Rovina, Nikoletta, et al.
Publicado: (2020)

Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome
por: Koupetori, Marina, et al.
Publicado: (2014)

Hellenic consensus on Helicobacter pylori infection
por: Georgopoulos, Sotirios D., et al.
Publicado: (2020)

Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control
por: Giamarellos-Bourboulis, Evangelos J., et al.
Publicado: (2023)

Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction
por: Ioakeimidou, A., et al.
Publicado: (2017)

Correction: Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control
por: Giamarellos-Bourboulis, Evangelos J., et al.
Publicado: (2023)

Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2017)

THE ROLE OF OBESITY AND PLASMA ADIPOCYTOKINES IN IMMUNE DYSREGULATION IN SEPSIS PATIENTS
por: de Nooijer, Aline H., et al.
Publicado: (2023)

Immunomodulatory intervention in sepsis by multidrug-resistant Pseudomonas aeruginosa with thalidomide: an experimental study
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2005)

Interferon-gamma reverses sepsis-induced immunoparalysis of monocytes in vitro
por: Mouktaroudi, M, et al.
Publicado: (2010)

Identification of suitable controls for miRNA quantification in T-cells and whole blood cells in sepsis
por: Hirschberger, Simon, et al.
Publicado: (2019)

Clarithromycin reverses sepsis-induced immunoparalysis of monocytes
por: Raftogiannis, M, et al.
Publicado: (2009)

Increases in inflammatory and CD14(dim)/CD16(pos)/CD45(pos) patrolling monocytes in sepsis: correlation with final outcome
por: Gainaru, Gabriela, et al.
Publicado: (2018)

Need for restoration of cortisol serum levels for successful antimicrobial therapy in experimental sepsis
por: Doulias, T, et al.
Publicado: (2013)

Detrimental effect of apoptosis of lymphocytes at an early time point of experimental abdominal sepsis
por: Atmatzidis, Stefanos, et al.
Publicado: (2011)

Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity
por: de Nooijer, Aline H., et al.
Publicado: (2023)

Effects of the common 34C>T variant of the AMPD1 gene on immune function, multiorgan dysfunction and mortality in patients with sepsis
por: Ramakers, B, et al.
Publicado: (2013)

Reply to Radermacher et al. on “Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus”
por: Renieris, Georgios, et al.
Publicado: (2021)

Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium
por: Rello, Jordi, et al.
Publicado: (2020)

High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure
por: Schrijver, Irene T., et al.
Publicado: (2022)

Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study
por: Pelekanou, Aimilia, et al.
Publicado: (2009)

Soluble fms-like tyrosine kinase 1, placental growth factor and procalcitonin as biomarkers of gram-negative sepsis: Analysis through a derivation and a validation cohort
por: Vittoros, Vasileios, et al.
Publicado: (2021)

Progression into sepsis: an individualized process varying by the interaction of comorbidities with the underlying infection
por: Sinapidis, Dimitrios, et al.
Publicado: (2018)

Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2006)

Kinetics of progenitor hemopoetic stem cells in sepsis: Correlation with patients survival?
por: Tsaganos, Thomas, et al.
Publicado: (2006)

Leukocyte Activation Profile Assessed by Raman Spectroscopy Helps Diagnosing Infection and Sepsis
por: Ramoji, Anuradha, et al.
Publicado: (2021)

Inhibition of caspase-1 activation in gram-negative sepsis and experimental endotoxemia
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kudbehddtvi0hv4b7lq3mnuv90